Mutagenesis in mammalian cells can be modulated by radiation-induced voltage-dependent potassium channels

A H Saad1, L Y Zhou, E K Lambe

  • 1Department of Radiation Oncology, Stanford University, CA 94305.

Mutation Research
|August 1, 1994
PubMed

Insights

Ionizing radiation increases mutation frequency in mammalian cells by activating potassium (K+) currents. Blocking these currents with specific blockers prevents radiation-induced mutagenesis, highlighting a novel role for membrane potential in DNA damage response.

Area of Science:

  • Cell Biology
  • Radiation Biology
  • Molecular Biology

Background:

  • The initial molecular events following ionizing radiation exposure in mammalian cells, leading to mutagenesis or DNA repair, remain largely unknown.
  • The potential role of the plasma membrane as an initiator of these cellular pathways is not understood.

Purpose of the Study:

  • To investigate the role of membrane voltage-dependent potassium (K+) currents in radiation-induced mutagenesis.
  • To determine if blocking these K+ currents can prevent mutagenesis following ionizing radiation exposure.

Main Methods:

  • Mammalian cells were exposed to 800 cGy of ionizing radiation.
  • Mutation frequency at the HGPRT locus was assessed.
  • Cells were treated with potassium channel blockers (CsCl, BaCl2) or a non-blocker (RbCl) post-irradiation.

Main Results:

  • Ionizing radiation significantly increased mutation frequency from 1.5 to 37.6 per 100,000 survivors.
  • Treatment with CsCl or BaCl2 completely abolished the radiation-induced increase in mutation frequency.
  • RbCl, which does not block K+ channels, was ineffective in preventing mutagenesis, while CsCl and BaCl2 did not affect radiation-induced cell killing.

Conclusions:

  • Membrane voltage-dependent potassium (K+) currents play a significant role in radiation mutagenesis.
  • Blocking these K+ currents represents a potential strategy to mitigate mutagenesis after radiation exposure.
  • These findings reveal a novel mechanism involving plasma membrane ion channels in the cellular response to DNA damage.

Related Concept Videos

Mutations01:39

Mutations

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).